Pfizer Inc. (PFE)
NYSE: PFE · Real-Time Price · USD
25.26
+0.59 (2.39%)
At close: Jul 28, 2026, 4:00 PM EDT
25.27
+0.01 (0.04%)
After-hours: Jul 28, 2026, 4:05 PM EDT
Pfizer Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 63,315 | 62,579 | 63,627 | 59,553 | 101,175 | 81,288 | |
Revenue Growth | 1.36% | -1.65% | 6.84% | -41.14% | 24.46% | 95.17% |
Cost of Revenue | 16,770 | 16,067 | 17,851 | 24,954 | 34,344 | 30,821 |
Gross Profit | 46,545 | 46,512 | 45,776 | 34,599 | 66,831 | 50,467 |
Selling, General & Admin | 13,724 | 13,794 | 14,730 | 14,771 | 13,677 | 12,703 |
Depreciation & Amortization Expenses | 4,847 | 4,874 | 5,286 | 4,733 | 3,609 | 3,700 |
Research & Development | 12,465 | 12,050 | 10,930 | 10,873 | 12,381 | 13,829 |
Other Operating Expenses | 7,604 | 8,274 | 6,807 | 3,165 | 2,437 | -4,076 |
Total Operating Expenses | 38,640 | 38,992 | 37,753 | 33,542 | 32,104 | 26,156 |
Operating Income | 7,905 | 7,520 | 8,023 | 1,057 | 34,727 | 24,311 |
Pretax Income | 7,906 | 7,520 | 8,023 | 1,058 | 34,729 | 24,311 |
Provision for Income Taxes | 384 | -266 | -28 | -1,115 | 3,328 | 1,852 |
Net Income | 7,522 | 7,787 | 8,051 | 2,172 | 31,401 | 22,459 |
Minority Interest in Earnings | 43 | 41 | 31 | 39 | 35 | 45 |
Earnings From Discontinued Operations | 12 | 25 | 11 | -15 | 6 | -434 |
Net Income to Common | 7,490 | 7,771 | 8,031 | 2,119 | 31,372 | 21,979 |
Net Income Growth | -4.98% | -3.24% | 279.00% | -93.25% | 42.74% | 139.97% |
Shares Outstanding (Basic) | 5,687 | 5,683 | 5,664 | 5,643 | 5,608 | 5,601 |
Shares Outstanding (Diluted) | 5,718 | 5,713 | 5,700 | 5,709 | 5,733 | 5,708 |
Shares Change | 0.26% | 0.23% | -0.16% | -0.42% | 0.44% | 1.35% |
EPS (Basic) | 1.31 | 1.37 | 1.42 | 0.38 | 5.59 | 3.92 |
EPS (Diluted) | 1.31 | 1.36 | 1.41 | 0.37 | 5.47 | 3.85 |
EPS Growth | -5.07% | -3.55% | 281.08% | -93.24% | 42.08% | 226.27% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 9,483 | 9,075 | 9,835 | 4,793 | 26,031 | 29,869 |
Free Cash Flow Growth | -15.48% | -7.73% | 105.19% | -81.59% | -12.85% | 145.29% |
Free Cash Flow Per Share | 1.66 | 1.59 | 1.73 | 0.84 | 4.54 | 5.23 |
Dividends Per Share | 1.720 | 1.720 | 1.680 | 1.640 | 1.600 | 1.560 |
Dividend Growth | 1.77% | 2.38% | 2.44% | 2.50% | 2.56% | 2.63% |
Gross Margin | 73.51% | 74.33% | 71.94% | 58.10% | 66.05% | 62.08% |
Operating Margin | 12.49% | 12.02% | 12.61% | 1.77% | 34.32% | 29.91% |
Profit Margin | 11.88% | 12.44% | 12.65% | 3.65% | 31.04% | 27.63% |
FCF Margin | 14.98% | 14.50% | 15.46% | 8.05% | 25.73% | 36.74% |
EBITDA | 14,492 | 14,112 | 15,036 | 7,347 | 39,791 | 29,502 |
EBITDA Margin | 22.89% | 22.55% | 23.63% | 12.34% | 39.33% | 36.29% |
EBIT | 7,905 | 7,520 | 8,023 | 1,057 | 34,727 | 24,311 |
EBIT Margin | 12.49% | 12.02% | 12.61% | 1.77% | 34.32% | 29.91% |
Effective Tax Rate | 4.86% | -3.54% | -0.35% | -105.39% | 9.58% | 7.62% |